Obsessive Compulsive Disorder
Not licensed for OCD but recommended by NICE CG31
Not licensed for this indication but recommended by The Maudsley Prescribing Guidelines in Psychiatry (12th edition) in combination with clomipramine as an option if other therapies have failed. In combination it is less well tolerated or has a weaker evidence base than formulary options
Recommended dose initially 20mg once daily increased if necessary to maximum of 40mg (20mg in those 65 years or older)
Drug Safety Update Citalopram and escitalopram: QT interval prolongation
Pack | Price |
---|---|
28 tablet | £0.66 |
Pack | Price |
---|---|
28 tablet | £0.72 |
30 tablet |
Pack | Price |
---|---|
28 tablet | £0.82 |
Pack | Price |
---|---|
15 ml | £3.91 |
Pack | Price |
---|---|
28 tablet | £0.91 |
Pack | Price |
---|---|
28 tablet | £1.15 |
Pack | Price |
---|---|
28 tablet | £1.35 |
Pack | Price |
---|---|
15 ml | £20.16 |
Pack | Price |
---|---|
30 capsule | £59.63 |
Pack | Price |
---|---|
28 capsule | |
30 capsule | £0.83 |
Pack | Price |
---|---|
30 capsule | £1.80 |
Pack | Price |
---|---|
30 capsule | £2.16 |
Pack | Price |
---|---|
30 capsule | £4.12 |
Pack | Price |
---|---|
28 tablet | £3.44 |
Pack | Price |
---|---|
70 ml | £2.58 |
Pack | Price |
---|---|
70 ml | £12.95 |
N.B Do not prescribe 25mg, 150mg or 200mg tablets. 50mg tablets can be halved.
Pack | Price |
---|---|
14 tablet | |
28 tablet | £1.06 |
30 tablet |
Pack | Price |
---|---|
28 tablet | £0.89 |
30 tablet |
An ECG and BP recording should be taken before commencing treatment for people at significant risk of cardiovascular disease
Pack | Price |
---|---|
100 capsule | |
28 capsule | £1.28 |
84 capsule |
Pack | Price |
---|---|
100 capsule | |
28 capsule | £1.48 |
84 capsule |
Pack | Price |
---|---|
100 capsule | |
28 capsule | £1.70 |
56 capsule |
Unlicensed for this indication but recommended by Maudsley
Add 5 - 20mg/day to an SSRI
Prescribers are reminded to be alert to the risk of addictive gambling and other impulse control disorders. It is important to advise patients, their families and friends to be alert to these risks.
Plasma concentration monitoring form ONLY for diagnosis of acute poisoning
Pack | Price |
---|---|
28 tablet | £1.12 |
Pack | Price |
---|---|
28 tablet | £1.18 |
Pack | Price |
---|---|
28 tablet | £1.29 |
Pack | Price |
---|---|
28 tablet | £11.09 |
Pack | Price |
---|---|
28 tablet | £78.06 |
Pack | Price |
---|---|
28 tablet | £78.06 |
Pack | Price |
---|---|
150 ml | £100.72 |
Unlicensed for this indication but recommended by Maudsley
Add 2-20mg/day to an SSRI
Pack | Price |
---|---|
20 tablet | £0.59 |
Pack | Price |
---|---|
20 tablet | £0.61 |
6 tablet | |
60 tablet |
Pack | Price |
---|---|
60 tablet | £1.28 |
Pack | Price |
---|---|
20 tablet | |
60 tablet | £1.55 |
Pack | Price |
---|---|
20 tablet | |
60 tablet | £1.72 |
Pack | Price |
---|---|
28 tablet | £3.04 |
30 tablet | |
60 tablet |
Pack | Price |
---|---|
100 ml | £4.10 |
Pack | Price |
---|---|
28 tablet | £23.86 |
Pack | Price |
---|---|
28 tablet | £24.02 |
Pack | Price |
---|---|
28 tablet | £44.43 |
Pack | Price |
---|---|
28 tablet | £43.49 |
Pack | Price |
---|---|
28 tablet | £50.35 |
Pack | Price |
---|---|
28 capsule | £2.66 |
56 capsule |
Pack | Price |
---|---|
28 capsule | £1.77 |
Pack | Price |
---|---|
56 capsule | £5.52 |
Pack | Price |
---|---|
28 capsule | £2.40 |
84 capsule |
Not licenced for this indication but the Maudsley Prescribing Guidelines in Psychiatry (12th edition) list as an option if other therapies have failed. It is less well tolerated or has a weaker evidence base than formulary options
Pack | Price |
---|---|
28 tablet | £2.84 |
30 tablet |
Pack | Price |
---|---|
28 tablet | £1.22 |
30 tablet |
Pack | Price |
---|---|
28 tablet | £2.77 |
30 tablet |
Pack | Price |
---|---|
30 tablet | £1.24 |
6 tablet |
Pack | Price |
---|---|
30 tablet | £1.34 |
Pack | Price |
---|---|
30 tablet | £1.79 |
Pack | Price |
---|---|
30 tablet |
Pack | Price |
---|---|
30 tablet |
Pack | Price |
---|---|
1 ml |
Women of child-bearing potential must use adequate contraception
High potential for withdrawal symptoms, other SSRIs are preferred
Pack | Price |
---|---|
28 tablet | £9.86 |
Pack | Price |
---|---|
14 tablet | |
28 tablet | |
30 tablet | £1.27 |
Pack | Price |
---|---|
30 tablet | £1.56 |
Pack | Price |
---|---|
28 tablet | |
30 tablet |
Pack | Price |
---|---|
150 ml | £9.12 |
Pack | Price |
---|---|
28 tablet | |
56 tablet | £1.82 |
60 tablet |
Pack | Price |
---|---|
28 tablet | |
56 tablet | £1.87 |
60 tablet |
Pack | Price |
---|---|
30 tablet | £6.60 |
Pack | Price |
---|---|
28 capsule | £5.25 |
Pack | Price |
---|---|
28 tablet | |
30 tablet | £2.60 |
Pack | Price |
---|---|
14 capsule | |
28 capsule | £2.60 |
30 capsule |
Pack | Price |
---|---|
28 tablet | |
30 tablet | £3.90 |
Pack | Price |
---|---|
14 capsule | |
28 capsule | £3.90 |
30 capsule |
Pack | Price |
---|---|
30 tablet | £33.60 |
Pack | Price |
---|---|
28 capsule | £47.11 |
30 capsule |
Restricted to initiation by specialists
Not licenced for this indication but the Maudsley Prescribing Guidelines in Psychiatry (12th edition) list as an option if other therapies have failed. It is less well tolerated or has a weaker evidence base than formulary options
Mainly useful in reducing associated anxiety
Only for careful short term use
Pack | Price |
---|---|
100 tablet | £30.74 |
60 tablet |
Pack | Price |
---|---|
100 tablet | £28.39 |
150 tablet | |
60 tablet |
Pack | Price |
---|---|
1 ml | |
150 ml |
Restricted to initiation by specialists
Not licenced for this indication but the Maudsley Prescribing Guidelines in Psychiatry (12th edition) list as an option if other therapies have failed. It is less well tolerated or has a weaker evidence base than formulary options
Used to augment an SSRI
Plasma concentration monitoring form ONLY for use before and during pregnancy
Pack | Price |
---|---|
14 tablet | |
21 tablet | |
30 tablet | |
42 tablet | |
56 tablet | £1.11 |
60 tablet |
Pack | Price |
---|---|
14 tablet | |
30 tablet | |
42 tablet | |
56 tablet | £1.41 |
Pack | Price |
---|---|
30 tablet | |
56 tablet | £1.49 |
Pack | Price |
---|---|
30 tablet | |
56 tablet | £2.44 |
Pack | Price |
---|---|
28 tablet | £6.03 |
30 tablet | |
56 tablet |
Pack | Price |
---|---|
28 tablet | |
30 tablet | |
56 tablet | £1.84 |
Pack | Price |
---|---|
56 tablet |
Pack | Price |
---|---|
30 tablet | |
56 tablet | £3.30 |
Restricted to initiation by specialist consultants only
Not licenced for this indication but Maudsley Prescribing Guidelines in Psychiatry (12th edition) list as an option if other therapies have failed. It is less well tolerated or has a weaker evidence base than formulary options
To augment an SSRI
Special warning for use in women of child-bearing potential
Topiramate may cause foetal harm and foetal growth restriction (small for gestational age and low birth weight) when administered to a pregnant woman. The North American Antiepileptic Drug pregnancy registry data for topiramate monotherapy showed an approximate 3-fold higher prevalence of major congenital malformations (4.3%), compared with a reference group not taking AEDs (1.4%). In addition, data from other studies indicate that, compared with monotherapy, there is an increased risk of teratogenic effects associated with the use of AEDs in combination therapy.
Before the initiation of treatment with topiramate in a woman of childbearing potential, pregnancy testing should be performed and a highly effective contraceptive method advised. The patient should be fully informed of the risks related to the use of topiramate during pregnancy.
MHRA: Introduction of new safety measures, including a Pregnancy Prevention Programme
Pack | Price |
---|---|
28 tablet | |
60 tablet | £1.44 |
Pack | Price |
---|---|
28 tablet | |
60 tablet | £1.52 |
Pack | Price |
---|---|
28 tablet | |
60 tablet | £2.35 |
Pack | Price |
---|---|
28 tablet | |
60 tablet | £14.44 |